Japan Tissue Engineering Co., Ltd. (TYO:7774)

Japan · Delayed Price · Currency is JPY

843.00

+12.00 (1.44%)

Oct 6, 2026, 3:30 PM JST

Market Cap	33.75B +69.2%
Revenue (ttm)	2.52B +3.4%
Net Income	-440.13M
EPS	-10.84
Shares Out	40.61M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,200
Open	832.00
Previous Close	831.00
Day's Range	829.00 - 846.00
52-Week Range	448.00 - 927.00
Beta	0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Japan Tissue Engineering

Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Contract, and Lab Site Project segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it offers EPI-MODEL, a reconstructed human epidermis model. Further, the company offers regenerativ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1999

Employees 200

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 7774

Full Company Profile

Financial Performance

In fiscal year 2026, Japan Tissue Engineering's revenue was 2.18 billion, a decrease of -11.12% compared to the previous year's 2.46 billion. Losses were -734.00 million, 187.8% more than in 2025.

Financial Statements